Controversies in the diagnosis of barrett esophagus and barrett-related dysplasia one pathologist'sperspective

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 10, 2010, Pages 1479-1484

  Goldblum, John R ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; GOBLET CELL; HUMAN; OBSERVER VARIATION; PATHOLOGY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GOBLET CELLS; HUMANS; OBSERVER VARIATION; SELECTION BIAS;

EID: 77958573965     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wild CP, Hardie LJ. Reflux, Barrett'soesophagus and adenocarcinoma: burning questions. Nat Rev Cancer. 2003;3(9):676-684.
2. Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology: updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett'sesophagus. Am J Gastroenterol. 2008; 103(3):788-797.
3. Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology: updated guidelines for the diagnosis, surveillance and therapy of Barrett'sesophagus. Am J Gastroenterol. 2002;97(8):1888-1895.
4. Spechler SJ. The columnar-lined esophagus: history, terminology and clinical issues. Gastroenterol Clin North Am. 1997;26(3):455-466.
5. Riddell RH, Odze RD. Definition of Barrett'sesophagus: time for a rethink- is intestinal metaplasia dead. Am J Gastroenterol. 2009;104(10):2588- 2594.
6. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar-lined (Barrett's) esophagus. Am J Clin Pathol. 1978;70(1):1-5.
7. Smith RR, Hamilton SR, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett'sesophagus: a clinicopathologic study of 26 patients. Am J Surg Pathol. 1984;8(8):563-573.
8. Skinner DB, Walther BC, Riddell RH, et al. Barrett'sesophagus: comparison of benign and malignant cases. Ann Surg. 1983;198(4):554-565.
9. Rosenberg JC, Budev H, Edwards RC, et al. Analysis of adenocarcinoma in Barrett'sesophagus utilizing a staging system. Cancer. 1985;55(6):1353-1360.
10. Paraf F, Flejou JF, Pignon JP, et al. Surgical pathology of adenocarcinoma arising in Barrett'sesophagus: analysis of 67 cases. Am J Surg Pathol. 1995;19(2): 183-191.
11. Guidelines for the diagnosis and management of Barrett'scolumnar-lined oesophagus. A report of the working party of the British Society of Gastroenterology. http://www.bsg.org.uk. Accessed January 2010.
12. Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett'sesophagus. Gut. 2006;55(4):442.
13. Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett'sesophagus. Dis Esophagus. 2008;21(7):645-649.
14. Gatenby PA, Ramus JR, Caygill CP, et al. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scand J Gastroenterol. 2008;43(5):524-530.
15. Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett'sesophagus: an observation comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102(6):1154-1161.
16. Kim SL, Waring JP, Spechler SJ, et al. Diagnostic inconsistencies in Barrett'sesophagus: Department of Veteranś Affairs Gastroesophageal Reflux Study Group. Gastroenterology. 1994;107(4):945-949.
17. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol. 2001;25(9): 1188-1193.
18. Rogge-Wolf C, Seldenrijk CA, Das KM, et al. Prevalence of mabDAS-1 positivity in biopsy specimens from the esophagogastric junction. Am J Gastroenterol. 2002;97(12):2979-2985.
19. Glickman JN, Chen YY, Wang HH, et al. The phenotypic characteristics of a distinctive multilayered epithelium suggest that it is a precursor in the development of Barrett'sesophagus. Am J Surg Pathol. 2001;25(5):569-578.
20. DeMeester SR, Wickramasinghe KS, Lord RV, et al. Cytokeratin and DAS-1 immunostaining reveals similarities among cardiac mucosa, CIM and Barrett'sesophagus. Am J Gastroenterol. 2002;97(10):2514-2523
21. Das KM, Prasad I, Garla S, et al. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med. 1994;120(9):753-756.
22. Phillips RW, Frierson HF Jr, Moskaluk CA, et al. CDX2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003; 27(7):1442, 1447.
23. Chu PG, Jiang Z, Weiss LM, et al. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27(7):953-959.
24. Hahn H, Blount PL, Ayub K, et al. Intestinal differentiation in metaplastic, non-goblet cells columnar epithelium in the esophagus. Am J Surg Pathol. 2009; 33(7):1006, 1015.
25. Chaves P, Crespo M, Ribeiro C, et al. Chromosomal analysis of Barrett'scells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol. 2007;20(7):788-796.
26. Liu W, Hahn H, Odze RD, et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009;104(4):816-824.
27. Romagnoli S, Roncalli M, Graziani D, et al. Molecular alterations of Barrett'sesophagus on microdissected endoscopic biopsies. Lab Invest. 2001; 81(2):241-247.
28. Kelty C, Gough M, Van Wyk Q. Barrett'soesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol. 2007;42(11):1271-1274.
29. Takubo K, Aida J. Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol. 2009;40(1):65-74.
30. Clark G, Smyrk TC, Burdiles P, et al. Is Barrett'smetaplasia the source of adenocarcinoma of the cardia? Arch Surg. 1994;129(6):609-614.
31. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction in Barrett'sesophagus. Gastroenterology. 1995; 109(5):1541-1546.
32. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14(11):931-968.
33. Appelman HD. Adenocarcinoma in Barrett mucosa treated by endoscopic mucosal resection. Arch Pathol Lab Med. 2009;133(11):1793-1797.
34. Lomo L, Blount PL, Sanchez CA, et al. Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett'sesophagus cohort. Am J Surg Pathol. 2006;30(4):423-435.
35. Zhang X, Huang Q, Goyal RK, et al. DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett'sesophagus and associated neoplastic lesions. Am J Surg Pathol. 2008;32(9):1327-1335.
36. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett'sesophagus. Hum Pathol. 1988;19(2):166-178.
37. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001; 32(4):368-378.
38. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term non-surgical management of Barrett'sesophagus with high-grade dysplasia. Gastroenterology. 2001;120(7):1607-1609.
39. Sabik JF, Rice, TW, Goldblum JR, et al. Superficial esophageal carcinoma. Ann Thorac Surg. 1995;60(4):896-901.
40. Downs-Kelly E, Mendelin JE, Bennett AE, et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pre-treatment Barrett'sesophagus biopsies. Am J Gastroenterol. 2008;103(9): 2333-2340.
41. Odze RD. Diagnosis and grading of dysplasia in Barrett'soesophagus. J Clin Pathol. 2006;59(10):1029-1038.
42. Zhu W, Appelman HD, Greenson JK, et al. A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma. Am J Clin Pathol. 2009;132(1):94-100.
43. Patil DT, Goldblum JR, Plesec T, et al. Prediction of adenocarcinoma on esophagectomy from pre-resection biopsies of Barrett'sesophagus with at least high-grade dysplasia: a comparison of two systems. Mod Pathol. 2010;23(suppl 1):161A.